Pub. Date : 2010 Feb
PMID : 19927151
5 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Comparison of the long-term effects of candesartan and olmesartan on plasma angiotensin II and left ventricular mass index in patients with hypertension. | olmesartan | angiotensinogen | Homo sapiens |
2 | Olmesartan is a potential ARB inducing activation of angiotensin-converting enzyme 2 (ACE2) that hydrolyzes Ang II to Ang 1-7, and has shown a beneficial effect on ventricular remodeling. | olmesartan | angiotensinogen | Homo sapiens |
3 | Indeed, a previous study reported that olmesartan treatment resulted in decreased plasma levels of Ang II and aldosterone. | olmesartan | angiotensinogen | Homo sapiens |
4 | In the olmesartan group, blood pressure did not change and plasma levels of Ang II decreased during 12 months of study, whereas LVMI was significantly decreased after 12 months (135+/-36 vs. 123+/-29 g m(-2); P<0.01).These findings indicate that replacing candesartan with olmesartan decreased LVMI in association with a sustained decrease of plasma Ang II over a 12-month period without changing blood pressure or plasma aldosterone in patients with essential hypertension. | olmesartan | angiotensinogen | Homo sapiens |
5 | In the olmesartan group, blood pressure did not change and plasma levels of Ang II decreased during 12 months of study, whereas LVMI was significantly decreased after 12 months (135+/-36 vs. 123+/-29 g m(-2); P<0.01).These findings indicate that replacing candesartan with olmesartan decreased LVMI in association with a sustained decrease of plasma Ang II over a 12-month period without changing blood pressure or plasma aldosterone in patients with essential hypertension. | olmesartan | angiotensinogen | Homo sapiens |